Koo Ki Dong, Kim Min Jung, Kim Sungsub, Kim Kyoung-Hee, Hong Sang Yong, Hur Gwong-Cheung, Yim Hyeon Joo, Kim Geun Tae, Han Hee Oon, Kwon O Hwan, Kwon Tae Sik, Koh Jong Sung, Lee Chang-Seok
LG Life Sciences, Ltd/R&D Park, 104-1 Munji-dong, Yuseong-gu, Daejeon 305-380, Republic of Korea.
Bioorg Med Chem Lett. 2007 Aug 1;17(15):4167-72. doi: 10.1016/j.bmcl.2007.05.046. Epub 2007 May 21.
Synthesis of a novel series of DPPIV inhibitors with 1,2,4- and 1,3,4-oxadiazolyl ketone derivatives and its structure-activity relationships are discussed. Compound 18h showed good inhibitory activity against DPPIV and favorable pharmacokinetic properties. In vivo pharmacodynamic efficacy and co-crystal structure of compound 18h with DPPIV is also described.
讨论了一系列具有1,2,4-和1,3,4-恶二唑基酮衍生物的新型二肽基肽酶IV(DPPIV)抑制剂的合成及其构效关系。化合物18h对DPPIV表现出良好的抑制活性和良好的药代动力学性质。还描述了化合物18h与DPPIV的体内药效学功效和共晶体结构。